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The UAF1-USP1 complex deubiquitinates FANCD2
during execution of the Fanconi anemia DNAdamage
response pathway. As such, UAF1 depletion results
in persistent FANCD2 ubiquitination and DNA dam-
age hypersensitivity. UAF1-deficient cells are also
impaired for DNA repair by homologous recombi-
nation. Herein, we show that UAF1 binds DNA and
forms a dimeric complex with RAD51AP1, an acces-
sory factor of the RAD51 recombinase, and a
trimeric complex with RAD51 through RAD51AP1.
Two small ubiquitin-like modifier (SUMO)-like do-
mains in UAF1 and a SUMO-interacting motif in
RAD51AP1 mediate complex formation. Importantly,
UAF1 enhances RAD51-mediated homologous DNA
pairing in amanner that is dependent on complex for-
mation with RAD51AP1 but independent of USP1.
Mechanistically, RAD51AP1-UAF1 co-operates with
RAD51 to assemble the synaptic complex, a critical
nucleoprotein intermediate in homologous recom-
bination, and cellular studies reveal the biological
significance of the RAD51AP1-UAF1 protein com-
plex. Our findings provide insights into an appar-
ently USP1-independent role of UAF1 in genome
maintenance.INTRODUCTION
Fanconi anemia (FA) is characterized by bone marrow failure,
developmental defects, and cancer predisposition (Cohn and
D’Andrea, 2008; Longerich et al., 2014). FA patient cells are
highly sensitive to DNA interstrand crosslink (ICL)-inducing
agents such as mitomycin C (MMC), and they accumulate chro-
mosomal aberrations upon exposure to these agents (Kee and
D’Andrea, 2010). FA proteins from 19 complementation groups
and associated factors execute the DNAdamage response (Lon-
gerich et al., 2014; Rickman et al., 2015; Wang et al., 2015).2118 Cell Reports 15, 2118–2126, June 7, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://Herein, DNA damage induces the mono-ubiquitination of the
FANCI-FANCD2 (ID2) heterodimer, licensing signaling and
DNA repair steps, including repair via homologous recombina-
tion (HR) mediated by the recombinase RAD51 (also known as
FANCR) and its ancillary factors (Cohn and D’Andrea, 2008;
Garcia-Higuera et al., 2001).
Timely deubiquitination of FANCD2 is critically important for
the FA pathway (Oestergaard et al., 2007). USP1 is the deubiqui-
tinating enzyme (DUB) for mono-ubiquitinated FANCD2 and
PCNA (Huang et al., 2006; Nijman et al., 2005). USP1 stably
associates with UAF1/WDR48, and its DUB activity and intracel-
lular stability are dependent on the latter (Cohn et al., 2007; Villa-
mil et al., 2012). UAF1 also interacts with and stimulates other
DUBs, such as USP12 and USP46 (Cohn et al., 2009; Sowa
et al., 2009).
Similar to USP1 deficiency, depletion of UAF1 results in
increased levels of mono-ubiquitinated FANCD2 and PCNA
and also leads to hypersensitivity to ICLs (Kim et al., 2009;
Park et al., 2013). A more severe impairment of HR occurs
in UAF1 mutant cells (Murai et al., 2011; Park et al., 2013).
Importantly, heterozygous Uaf1+/mouse embryonic fibroblasts
exhibit a marked hypersensitivity to MMC, etoposide, and other
DNA-damaging agents and are compromised for HR (Park et al.,
2013).
In a large-scale proteomic analysis, UAF1-USP1 was found to
associate with RAD51AP1 (Sowa et al., 2009), a DNA binding
protein and co-factor for RAD51 (Modesti et al., 2007; Wiese
et al., 2007). Here we demonstrate that UAF1 binds DNA and
employs two small ubiquitin-like modifier (SUMO)-like domains
(SLDs) to associate with RAD51AP1 via a SUMO-interacting
motif (SIM) in the latter. Importantly, we find that UAF1 syner-
gizeswith RAD51AP1 to enhanceRAD51-mediated homologous
DNA pairing specifically by promoting the assembly of the syn-
aptic complex, in which single-stranded DNA (ssDNA) derived
from the nucleolytic processing of a primary lesion is homolo-
gously aligned with a duplex molecule (San Filippo et al.,
2008). Physical interaction between RAD51AP1 and UAF1 is
indispensable for functional synergy in vitro and, accordingly,
for protein function in HR and DNA damage repair. Our results
shed light on a USP1-independent role of UAF1 in genome
maintenance.).
creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. RAD51AP1-UAF1 Complex Formation via the SIM and SLD1-SLD2 Domains in These Proteins
(A) Strep II-tagged UAF1, UAF1-436X, MBP-tagged UAF1-SLD1, UAF1-SLD2, and UAF1-SLD1/SLD2 (SLD1/2) were incubated with GST-tagged RAD51AP1,
and protein complexes were captured on glutathione resin and analyzed by SDS-PAGE. S, supernatant containing unbound proteins; W, wash; E, SDS eluate of
the glutathione resin; FL, full length.
(B) Alignment of UAF1-SLD1 against SUMO2. The asterisk highlights the K459 and K33 residues in UAF1 and SUMO2, respectively. The arrows and helices
represent the b sheet and a helix, respectively.
(C) GST-tagged RAD51AP1 was incubated with Strep II-tagged UAF1 (WT) or the indicated UAF1mutant, and protein complexes were captured with glutathione
resin. Analysis was as in (A).
(D) Sequence analysis reveals a SIM between amino acid residues 137–142 in RAD51AP1. The asterisks highlight the residues targeted for mutagenesis.
Hs, Homo sapiens; Mm, Mus musculus; Bt, Bos taurus; Rn, Rattus norvegicus; Pt, Pan troglodytes.
(E) GST-tagged RAD51AP1 (WT) or the indicated RAD51AP1 mutant was incubated with Strep II-tagged UAF1, and protein complexes were captured with
glutathione resin. Analysis was as above.
(F) Schematic highlighting the RAD51AP1-UAF1 interaction domains.
See also Figure S1.RESULTS
Definition of the RAD51AP1-UAF1 Interaction Interface
We expressed UAF1 in insect cells and devised a method for its
purification (see Experimental Procedures), whereas RAD51AP1
was purified following our published procedure (Wiese et al.,
2007). Affinity pull-down verified that RAD51AP1 and UAF1
form a stoichiometric complex (Figure 1A, lane 3).
UAF1 possesses two SLDs within its C-terminal half, with
SLD2 implicated in complex formation with RAD51AP1 (Yang
et al., 2011). We purified maltose binding protein (MBP)-tagged
SLD1, SLD2, SLD1-SLD2, and the N-terminal 436 residues
(436X) to test for RAD51AP1 binding. The results revealed that,
although the 436X fragment does not interact with RAD51AP1
(Figure 1A, lane 6), both SLD1 and SLD2 are capable of doing
so, but SLD1-SLD2 has a higher affinity for RAD51AP1 (Fig-
ure 1A, lanes 9, 12, and 15).Lysine 595 (K595) and histidine 599 (H599) in SLD2 are likely
analogous to K33 and H37 in SUMO-2 (Yang et al., 2011),
which are important for association with the SIM in client pro-
teins (Sekiyama et al., 2008). Using the Phyre2 algorithm (Kelley
et al., 2015), we identified K459 in SLD1 to be analogous to K33
in SUMO-2 (Figure 1B). We changed K459 in SLD1 to glutamic
acid (K459E) and K595 and H599 in SLD2 individually or
together to glutamic acid and alanine (K595E and H599A).
By affinity pull-down, we found that the K459E mutant is
attenuated for RAD51AP1 interaction (Figure 1C, lane 6),
whereas K595E and H599A single mutants are interaction-pro-
ficient (Figure S1A), although the K595E/H599A double mutant
(referred to as the EA mutant) is impaired in this regard (Fig-
ure 1C, lane 9). Moreover, we constructed the K459E/K595E/
H599A triple mutant (referred to as the EEA mutant) and
showed that it is more impaired for RAD51AP1 interaction
than the K459E and EA mutants (Figure 1C, lane 12). Thus,Cell Reports 15, 2118–2126, June 7, 2016 2119
SLD1 and SLD2 of UAF1 both contribute to RAD51AP1
interaction.
By testing RAD51AP1 fragments (Dunlop et al., 2011), we
discovered that the UAF1 interaction domain resides within
amino acid residues 95–187 of the protein (Figure S1B, lane 9).
Because our result differs from a published report suggesting
that residues 11–24 of RAD51AP1 are important for UAF1 inter-
action (Yang et al., 2011), we constructed and tested the DN25
mutant missing the N-terminal 25 residues but found that it is
fully capable of UAF1 binding (Figure S1C, lane 6).
We examined additional RAD51AP1 fragments and found that
the 1–145 fragment is proficient in UAF1 binding but the 1–132
fragment is not (Figure S1D). Thus, the region within residues
133–145 of RAD51AP1 is indispensable for UAF1 interaction.
Consistent with the fact that UAF1 engages RAD51AP1 via two
SLDs, we identified an I/L/V-rich sequence between residues
137–142 of RAD51AP1 that fits the SIM signature (Figure 1D;
Hecker et al., 2006; Sun and Hunter, 2012). Indeed, the L137A/
I140A (LI2A) and I140A/V142A (IV2A) RAD51AP1 mutants are
both compromised for UAF1 interaction (Figure 1E). Thus, the
RAD51AP1-UAF1 complex is formed via interaction between
SLD1-SLD2 of UAF1 and the SIMmotif in RAD51AP1 (Figure 1F).
We verified that the UAF1 mutants possess wild-type (WT)
affinity for USP1 and FANCI (Figures S1E and S1F) and that
the RAD51AP1 mutants retain the ability to interact with
RAD51 (Figure S1G). We also tested the UAF1 mutants for the
ability to stimulate theDUB attribute of USP1 using ubiquitin vinyl
sulfone (Ub-VS) as an activity probe (Borodovsky et al., 2001).
The results showed that the UAF1 mutants are as capable as
the wild-type protein in enhancing USP1 activity (Figure S1H).
Thus, themutants that we constructed (Table S1) are specifically
compromised for RAD51AP1-UAF1 complex formation.
Association of UAF1 with RAD51 via RAD51AP1
RAD51AP1 physically interacts with RAD51 (Modesti et al., 2007;
Wiese et al., 2007). We found that UAF1 associates with RAD51
only when RAD51AP1 is present (Figure 2A, lane 18), suggesting
a bridging role of RAD51AP1 (Figure 2A). Consistent with this
deduction, affinity pull-down showed that SLD1-SLD2 of UAF1
interacts with RAD51 via RAD51AP1, whereas the UAF1-EEA
and RAD51AP1-LI2A mutants (Figures 1C and 1E) fail to form
the trimer (Figure 2A). The trimeric complex is species-specific
because yeast Rad51 has no affinity for RAD51AP1-UAF1
(Figure 2B).
DNA Binding Activity in UAF1
RAD51AP1 possesses a DNA binding activity (Modesti et al.,
2007; Wiese et al., 2007). Importantly, we found that UAF1
and UAF1-436X both bind ssDNA and double-stranded DNA
(dsDNA) with nanomolar affinity (Figures 2C and 2D) and that
the UAF1-EEA and RAD51AP1 IV2A and LI2A mutants possess
wild-type DNA binding activity (Figure S2).
Synergistic Action of RAD51AP1 and UAF1 in RAD51
Recombinase Enhancement
We used the D-loop assay (Wiese et al., 2007; Figure 3A) to test
UAF1 for the ability to enhance the recombinase activity of
RAD51. The results showed that UAF1 does not affect D-loop2120 Cell Reports 15, 2118–2126, June 7, 2016formation (Figure 3B, lanes 3–5), whereas, as expected (Wiese
et al., 2007), RAD51AP1 stimulates the D-loop reaction (Fig-
ure 3B, lane 6). Interestingly, the combination of RAD51AP1
and UAF1 enhanced D-loop formation severalfold compared
with RAD51AP1 alone (Figure 3B, lanes 8–10). The action
of RAD51AP1-UAF1 is species-specific because the D-loop
reaction catalyzed by yeast Rad51 was not affected by it
(Figure S3A).
Importance of the RAD51AP1-UAF1 Complex in RAD51
Enhancement
We asked whether synergistic enhancement of the D-loop reac-
tion by RAD51AP1 and UAF1 is contingent upon complex forma-
tion between them. Importantly, the results showed that UAF1
mutants (K459E, EA, and EEA) compromised for RAD51AP1
interaction (Figure 1C) are less effective in the D-loop reaction
(Figure 3C; Figure S3B), whereas the K595E andH599Amutants,
which retain the ability to bind RAD51AP1 (Figure S1A), remain
proficient in this regard (Figure S3B). Conversely, we found
that the RAD51AP1 IV2A and LI2A mutants with impaired
UAF1 binding fail to synergize with UAF1 in the D-loop reaction
(Figure 3D). We note that these RAD51AP1 mutants are as
capable as the wild-type counterpart in RAD51 enhancement
(Figure 3D). Taken together, the results indicate that complex
formation between RAD51AP1 and UAF1 is indispensable for
their functional synergy in the D-loop reaction.
We previously described mutants of RAD51AP1 that are either
defective in DNA binding (the N-K6RA/C-K7WA mutant) or
in RAD51 interaction (the H329A mutant) (Dunlop et al., 2012;
Wiese et al., 2007). Affinity pull-down showed that both
RAD51AP1 mutants are proficient in complex formation with
UAF1 (Figures S3C and S3D). Importantly, these RAD51AP1mu-
tants could not stimulate the D-loop reaction even with UAF1
present (Figure S3E). Therefore, the RAD51 interaction and
DNA binding attributes of RAD51AP1 are critically important
for the functionality of the RAD51AP1-UAF1 complex.
UAF1-USP1 readily associates with RAD51AP1 to form a
trimeric complex (Figure S3F). However, like UAF1, neither
USP1 nor the UAF1-USP1 complex exerts any influence on the
D-loop reaction (Figure S3G; data not shown). Moreover, we
verified that UAF1-USP1 is no more effective than UAF1 in the
D-loop reaction (Figure S3H) and that USP1 fails to restore func-
tional synergy of the UAF1 EEA mutant with RAD51AP1 (Fig-
ure S3I). Thus, USP1 plays no role in the D-loop reaction.
Function of RAD51AP1-UAF1 in Synaptic Complex
Assembly
RAD51AP1 enhances synaptic complex assembly that is medi-
ated by the RAD51-ssDNA nucleoprotein filament, commonly
referred to as the presynaptic filament (Dray et al., 2010). As re-
ported previously and confirmed here, RAD51AP1 stimulated
duplex capture (Figure 4A) by the RAD51 presynaptic filament
(Figure 4B, lane 9). As in the D-loop assay, although UAF1 alone
had no effect on duplex capture (Figure 4B, lanes 5 and 6), its
addition with RAD51AP1 enhanced the reaction severalfold
over the level of RAD51AP1 alone (Figure 4B, lanes 10–12).
Importantly, the UAF1 K459E and EEAmutants (Figure 1C; Table
S1), which are deficient in RAD51AP1 interaction, were less
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Figure 2. Association of UAF1 with RAD51
via RAD51AP1 and DNA-Binding Activity
in UAF1
(A) Strep II-tagged UAF1 (WT) or UAF1-EEA was
incubated with RAD51AP1, RAD51AP1-LI2A, and
RAD51 alone or in combination. Protein com-
plexes were captured on Strep-Tactin resin, and
the different fractions were analyzed as in Fig-
ure 1A. MBP-tagged UAF1 SLD1-SLD2 (SLD1/2)
was similarly incubated with RAD51AP1 and
RAD51, and amylose resin was used to capture
the trimeric protein complex. A control experiment
confirmed that RAD51AP1-RAD51 does not bind
amylose resin nonspecifically (data not shown).
(B) Strep II-tagged UAF1 was incubated with
RAD51AP1, yeast Rad51 or their combination, and
Strep-Tactin pull-down was carried out as in (A).
(C) Strep II-tagged UAF1-FL or UAF1-436X was
incubated with radiolabeled 80-mer ssDNA. The
mobility shift of the DNA was analyzed. Treatment
with SDS and proteinase K (SDS+PK) released
the DNA from nucleoprotein complexes. The data
were quantified and plotted. The error bars
represent mean values ± SD of data from three
independent experiments.
(D) The ability of UAF1 and UAF1-436X to bind
radiolabeled dsDNA was analyzed as in (C).
See also Figure S2.effective in the reaction (Figure S4A). Notably, the RAD51
presynaptic filament failed to capture ssDNA even with
RAD51AP1-UAF1 present (Figure S4B).
We have shown previously that RAD51AP1 enhances synaptic
complex formation (Figure 4C), and this was confirmed here (Fig-
ure 4D, lane 7). Although UAF1 alone was unable to promote
synaptic complex formation, its co-addition with RAD51AP1
led to strong synergy (Figure 4D, lanes 8 and 9). Functional
synergy was not observed for the UAF1-EEA, RAD51AP1-Cell RVI2A, and RAD51AP1-LI2A mutants,
which are compromised for protein com-
plex formation (Figures S4C and S4D).
Taken together, the results unveil a role
of the RAD51AP1-UAF1 complex in the
synaptic stage of the HR process.
Dependence of DNA Damage
Repair and HR on the RAD51AP1-
UAF1 Complex
Consistent with affinity pull-down results
(Figure 1), although UAF1 co-immunopre-
cipitated RAD51AP1, the K459E and EEA
mutants failed to do so (Figure 5A). In
contrast, USP1 co-immunoprecipitated
with UAF1 and its mutant forms. A previ-
ous study provided evidence that K595
in SLD2 of UAF1 contributes to ELG1
interaction (Yang et al., 2011), which
was confirmed by diminished ELG1,
which co-immunoprecipitated with the
EEA mutant harboring the K595E muta-tion, although the UAF1 SLD1-K459E mutation had no such
effect (Figure 5A). Although RAD51AP1 co-immunoprecipitated
UAF1 efficiently, the IV2A and LI2A mutants were largely unable
to do so (Figure S5A).
As expected (Murai et al., 2011; Park et al., 2013), UAF1 deple-
tion in human cells led to hypersensitivity to MMC, camptothecin
(CPT), and olaparib (a poly ADP-ribose polymerase [PARP] inhib-
itor) (Figures 5B and 5C). Complementation with wild-type UAF1
conferred resistance to MMC, CPT, and olaparib, but neither theeports 15, 2118–2126, June 7, 2016 2121
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Figure 3. Synergistic Action of RAD51AP1
and UAF1 in RAD51-Mediated D-loop
Formation
(A) Schematic of the D-loop assay.
(B) RAD51, RAD51AP1, Strep II-tagged UAF1, and
the indicated combinations of these proteins were
tested for the ability to form D-loops. The per-
centages of D-loop product from three indepen-
dent experiments are shown as the mean ± SD.
(C) The K459E and EEA mutants of UAF1 were
tested with RAD51AP1 in the D-loop reaction.
Data analysis was as in (B).
(D) The IV2A and LI2A mutants of RAD51AP1 were
tested with UAF1 in the D-loop reaction.
See also Figure S3.K459E nor EEA mutant could fully restore resistance (Figures 5B
and 5C) even though UAF1-depleted cells and cells expressing
the mutants had the wild-type level of RAD51AP1 (Figure 5B).
Consistent with these data, the RAD51AP1 IV2A and LI2A mu-
tants were less capable than their wild-type counterpart in
restoring MMC resistance to cells (Figure S5B).
We found that, although cells depleted for UAF1 or expressing
the UAF1 mutants exhibit a WT cell-cycle profile without DNA
damage, CPT treatment leads to an increased accumulation of
mutant UAF1 cells in G2/M phase (Figure S5C). We also noted
that cells expressing the UAF1 mutants harbor mostly deubiqui-
tinated FANCD2, whereas UAF1-depleted cells showed an
elevated level of mono-ubiquitinated FANCD2 (Figure 5B), as
shown previously (Murai et al., 2011; Park et al., 2013). These
observations are consistent with our finding that complexes of
USP1 and the UAF1 mutants retain DUB activity (Figure S1H).
We next inquired whether HR is reliant on the RAD51AP1-
UAF1 complex. As expected (Park et al., 2013; Yang et al.,
2011), UAF1 knockdown caused a 3- to 4-fold decrease in HR
proficiency (Figure 5D, right, lane 2). Importantly, although intro-
ducing the UAF1 gene restored HR proficiency, the K459E-
and EEA-mutant genes were less capable of complementation
(Figure 5D, right, lanes 3–5). Similarly, RAD51AP1 knockdown
or IV2A and LI2A mutant expression led to HR impairment
(Figure S5D).2122 Cell Reports 15, 2118–2126, June 7, 2016The findings above reveal that cells
expressing UAF1 mutants are less sensi-
tive to DNA damage and remain partially
competent for HR compared with cells
depleted for UAF1. Consistent with pub-
lished results (Murai et al., 2011), genetic
data showed that USP1 depletion in
human cells by small interfering RNA
(siRNA) treatment engenders a lesser de-
gree of CPT sensitivity and HR deficiency
than UAF1 depletion but exerts no addi-
tive effect in the UAF1-deficient back-
ground (Figures S5E–S5G). Importantly,
combining the UAF1 K459E or EEAmuta-
tion with USP1 depletion enhances CPT
sensitivity and decreases HR proficiency
to the levels seen in UAF1-deficient cells(Figures S5E–S5G). These results provide evidence that the
DNA repair function of the RAD51AP1-UAF1 complex is likely
USP1-independent. However, we cannot exclude the possibility
that UAF1 also contributes to HR through other associated
DUBs, such as USP12 and USP46 (Cohn et al., 2009; Sowa
et al., 2009).
DISCUSSION
We have provided biochemical and genetic data to elucidate
the role of the RAD51AP1-UAF1 complex in HR and DNA dam-
age repair (Figure 5E). Specifically, we have shown that UAF1
possesses (1) a DNA binding activity and (2) a SIM motif in
RAD51AP1 and the SLD1-SLD2 domain of UAF1 mediate pro-
tein complex formation, (3) RAD51AP1 provides a bridging func-
tion between UAF1 and RAD51, (4) UAF1 synergizes with
RAD51AP1 in the RAD51-mediated D-loop reaction and that
functional synergy requires the RAD51AP1-UAF1 complex and
also the DNA and RAD51 binding attributes of RAD51AP1, (5)
the RAD51AP1-UAF1 complex works in conjunction with the
RAD51 presynaptic filament in the capture of the duplex DNA
partner and in the assembly of the synaptic complex, and (6)
mutants impaired for RAD51AP1-UAF1 complex formation
are compromised for the ability to repair DNA damage and
to execute HR. Thus, our work unveils a USP1-independent
A B
C D
Figure 4. Duplex DNA Capture and Synaptic Complex Assembly by RAD51-RAD51AP1-UAF1
(A) Schematic of the duplex capture assay.
(B) RAD51AP1, Strep II-tagged UAF1, or a combination of these proteins was incubated with the RAD51 presynaptic filament, and the ability to capture dsDNA
was analyzed. The percentages of captured dsDNA are shown. The error bars represent mean values ± SD of data from three independent experiments.
(C) Schematic of the synaptic complex assembly as assayed by protection against SspI digestion.
(D) RAD51AP1, Strep II-tagged UAF1, or their combination was incubated with the RAD51 presynaptic filament, and the protection of dsDNA against SspI
digestion was analyzed. Lane 1 was the control without SspI treatment. The protected DNA was quantified and plotted. Error bars are mean ± SD of three in-
dependent experiments.
See also Figure S4.function of UAF1 in DNA repair and suggests the possibility that
RAD51AP1 represents yet another candidate FA gene. We note
that, even though USP1 has little or no effect on the functional
attributes of RAD51AP1-UAF1 in vitro or in cells, it likely contrib-
utes to DNA damage repair and HR via its DUB activity (Kim
et al., 2009; Murai et al., 2011; this study).
RAD51AP1-deficient human cells are able to assemble RAD51
foci upon DNA damage occurrence (Wiese et al., 2007). Like-
wise, DT40 UAF1// chicken cells are proficient in DNA dam-
age-induced Rad51 focus formation (Murai et al., 2011). Consis-
tent with these published results, we found that HeLa cells
depleted of UAF1 remain competent for DNA damage-induced
RAD51 focus formation (Figure S5H). Thus, the RAD51AP1-
UAF1 complex is likely specific for the synaptic stage of HR.
It will be of interest to determinewhether DNAbinding byUAF1
is relevant for HR and the integrity of the FA pathway. To accom-
plish this goal, onewould need amutant of UAF1 that is defective
in DNA binding but retains the ability to interact with RAD51AP1,
USP1, and other partners. Moreover, it will be important to deter-
mine how USP1 influences HR via its DUB activity. Specifically,
there are likely unidentified USP1 substrates whose timely
deubiquitination helps ensure the proper execution of HR.RAD51AP1 enhances homologous DNA pairing mediated by
the meiosis-specific recombinase DMC1 by facilitating the
assembly of the synaptic complex (Dray et al., 2011). Future
work will determine the role, if any, of UAF1 in DMC1-dependent
HR. We note that SLD2 of UAF1 is involved in ELG1 interaction
(Yang et al., 2011; Figure 5A), and it will be of interest to test
whether ELG1 affects synaptic complex formation mediated by
RAD51-RAD51AP1-UAF1.
EXPERIMENTAL PROCEDURES
Mutant Construction, Protein Expression, and Protein Purification
The details are provided in the Supplemental Experimental Procedures.
Affinity Pull-Down Assay
Glutathione S-transferase (GST)- or MBP-tagged RAD51AP1 (3 mg) and
UAF1 (3 mg) were incubated in 30 ml reaction buffer (25 mM Tris-HCl
[pH 7.5], 10% glycerol, 0.5 mM EDTA, 0.01% Igepal, 1 mM DTT, and
150 mM KCl) on ice for 30 min, and then 15 ml glutathione resin (GE Health-
care) or amylose resin (New England Biolabs) was added to capture
RAD51AP1 through its GST or MBP tag, respectively. After gentle mixing
at 4C for 1 hr, the resin was washed three times with 30 ml of buffer and
then treated with 30 ml of 2% SDS to elute bound proteins. The supernatant,
last wash, and SDS eluate (10 ml each) were analyzed by 10% SDS-PAGECell Reports 15, 2118–2126, June 7, 2016 2123
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Figure 5. Role of the RAD51AP1-UAF1 Complex in DNA Damage Repair and HR
(A) Extracts from HeLa cells expressing WT or the mutant form (K459E or EEA) of FLAG-tagged UAF1 were subject to co-immunoprecipitation analysis with anti-
FLAG M2 agarose resin. Proteins were revealed by western blotting.
(legend continued on next page)
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and Coomassie blue staining. For affinity pull-down reactions involving
Strep II- or MBP-tagged UAF1, Strep-Tactin or amylose resin was used to
capture the tagged protein.
DNA Mobility Shift Assay
RAD51AP1 or the indicated mutant (20–400 nM) and UAF1 or the indicated
mutant (50–400 nM) were incubated with radiolabeled ssDNA (2.4 mM
nucleotides) or dsDNA (2.4 mM base pairs) (oligonucleotides P1 and
P1/P2 in Table S2, respectively) in 10 ml reaction buffer (25 mM Tris-HCl
[pH 7.5], 50 mM KCl, 1 mM DTT, 100 mg/ml BSA, and 1.5 mM MgCl2)
at 37C for 10 min. The reaction mixtures were resolved in 4% polyacryl-
amide gels in Tris-borate-EDTA (TBE) buffer (40 mM Tris-HCl [pH 8.3],
45 mM boric acid, and 1 mM EDTA) at 4C. After gel-drying, the radiola-
beled DNA species were visualized and quantified by phosphorimaging
analysis.
D-loop Assay
The assay was conducted as described previously (Wiese et al., 2007). Briefly,
32P-labeled 90-mer oligonucleotide (2.5 mMnucleotides; Table S2) and RAD51
(0.8 mM) were pre-incubated in 10.5 ml of reaction buffer, followed by the
addition of RAD51AP1 (100 nM), UAF1 (100–400 nM), or the combination of
the two proteins in 1 ml and a 5-min incubation. Then pBlueScript replicative
form I DNA (35 mM base pairs) was added in 1 ml to complete the reaction,
whichwas incubated for 10min before gel electrophoresis and phosphorimag-
ing analysis.
Synaptic Complex Assembly Assay and Cell-Based Experiments
Details on duplex capture, synaptic complex assembly and cell culture, trans-
fection, co-immunoprecipitation, cell survival assay, cell-cycle analysis, HR
assay, and immunofluorescence analysis are provided in the Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.05.007.
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